Lumida
/RYM
⌘K
RYM

RYM

RYM
$22.22USD-2.33%-0.53 today

MARKET CAP

48.4M

P/E (TTM)

FWD P/E

DAY RANGE

$22 – $23

52W RANGE

$14
$54

The case for & against

Bull & Bear analysis

Bearish

RYTHM Inc. (RYM) is an emerging player in the health and wellness sector, focusing on cannabis-based products and services. The company is positioned within the broader context of the ongoing legalization of cannabis and the increasing acceptance of its medicinal properties. RYTHM is part of a rapidly growing industry fueled by changing consumer preferences and a push towards holistic health solutions. However, its recent share issuance proposal raises concerns about investor dilution and control.

Bull says

  • Growth factor of 0.92 indicates strong potential in expanding cannabis market.
  • Rate sensitivity (1.37) suggests lower capital costs if rates rise.
  • Dividend yield of 0.56% provides income support amid volatility.
  • QS score of 3.90 reflects solid fundamental stability and risk-adjusted profile.
  • Book-to-Price ratio of 1.51 implies possible undervaluation relative to assets.
  • Innovative products and variant perception could drive valuation outperformance.

Bear says

  • Insiders sold US$357k net over last year, flagging weak insider conviction.
  • Share issuance could grant one entity 90.1% control, severely diluting equity.
  • Stock dropped 17.7% in 10 days with weak momentum factors.
  • Negative earnings yield (-2.58%) and weak profitability factors raise distress concerns.
  • High short interest reflects widespread bearish sentiment on recovery prospects.
  • Trading volume at 1.42K vs. 14.07K avg shares indicates low liquidity.